share

  • Werum appoints head of new central business unit

    Richard Nagorny is in charge of the newly established central business unit Shared Service Center at Werum Software & Systems AG. He is responsible for finances, controlling, procurement, human resources, internal IT, and Infrastructure. He reports directly to the executive board. Nagorny held the CFO position at the pharmaceutical group AstraZeneca Germany in Wedel before joining Werum.

    share | 28 November 2011

  • Helm acquires shares in Amarin

    Helm has purchased a 30 percent shareholding in Amarin Technologies, a privately owned pharmaceutical development company in Buenos Aires, Argentina. Amarin has more than 20 years of experience in the technology of transdermal delivery systems an…

    share | 09 February 2011

  • Bigger market share for RA biologic treatments

    Use of biologic disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis is set to increase dramatically over the next five years, says independent market analyst Datamonitor . Despite their considerable cost, rheum…

    share | 15 October 2010

  • New multiple sclerosis drugs set to capture market share

    The Russian approval of Merck Serono’s Movectro (oral cladribine) is a landmark in the treatment for relapse-remitting multiple sclerosis (RRMS) patients, as it becomes the world’s first oral disease-modifying MS therapy to be granted marketing a…

    share | 19 July 2010

  • Agilent Introduces Software for Labs

    Agilent Technologies has introduced the OpenLAB software portfolio, designed as a way for labs to efficiently capture, share, review and archive scientific data. "Customers want solutions that reduce the time from discovery to delivery of a new ch…

    share | 08 March 2010

  • Invitrogen shareholders approve merger with Applied Biosystems

    Invitrogen Corp announced that its shareholders have voted to approve the company's proposed merger with Applied Biosystems at a special meeting of shareholders held on October 28, 2008. The preliminary tabulation indicates that more than 98% of t…

    share | 04 November 2008

  • Eisai Starts Cash Tender Offer For Outstanding Shares Of MGI PHARMA

    Eisai Co., Ltd., a research-based human health care (hhc) company, has announced the commencement of its cash tender offer for all outstanding shares of the common stock of MGI PHARMA, Inc. for US$41.00 per share. The tender offer is being made by…

    share | 02 January 2008

  • India’s Lupin Acquires Majority Share in Japanese Generics Company

    Mumbai-based Lupin Limited recently announced that it has completed arrangements to acquire a significant majority stake in Kyowa Pharmaceutical Industry Co. Ltd. (Kyowa), a leading Japanese generics company. Kyowa, with sales of $0.06 billion for…

    share | 01 November 2007